Results 151 to 160 of about 833,621 (293)

Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera

open access: yesInternational Journal of Infectious Diseases, 2019
Ruxolitinib is a JAK-1/JAK-2 inhibitor indicated for the treatment of polycythemia vera and primary or secondary myelofibrosis. Only one patient (0.2%) was diagnosed with tuberculosis among the 485 patients receiving ruxolitinib in the four pivotal ...
Sylvain Lescuyer   +9 more
doaj  

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

open access: yesNature Reviews Microbiology, 2019
C. Meehan   +40 more
semanticscholar   +1 more source

Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

open access: yesJournal of Clinical Microbiology, 1997
J. Kamerbeek   +14 more
semanticscholar   +1 more source

Mycobacterium Tuberculosis Infection: Participation of TH1, TH2, TH17 and Regulatory T Cells in the Immune Response

open access: yesActa Medica Iranica, 2018
Mycobacterium tuberculosis, the etiologic agent of Tuberculosis, is a pathogen that is widely distributed geographically. Tuberculosis is classified as a granulomatous inflammatory condition where effector cells accumulate at the site of mycobacterial ...
Gerardo Fernando Fernández Soto   +5 more
doaj  

Home - About - Disclaimer - Privacy